Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP662809.RA9lWB71G1KR9s8CjH4180GmB14zCze-jwtYpkIino6kA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP662809.RA9lWB71G1KR9s8CjH4180GmB14zCze-jwtYpkIino6kA130_assertion type Assertion NP662809.RA9lWB71G1KR9s8CjH4180GmB14zCze-jwtYpkIino6kA130_head.
- NP662809.RA9lWB71G1KR9s8CjH4180GmB14zCze-jwtYpkIino6kA130_assertion description "[Diazoxide is the first-line drug for the rare forms of CHI for long-term treatment but is not entirely effective in some of these rarer defects (GCK, MCT1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662809.RA9lWB71G1KR9s8CjH4180GmB14zCze-jwtYpkIino6kA130_provenance.
- NP662809.RA9lWB71G1KR9s8CjH4180GmB14zCze-jwtYpkIino6kA130_assertion evidence source_evidence_literature NP662809.RA9lWB71G1KR9s8CjH4180GmB14zCze-jwtYpkIino6kA130_provenance.
- NP662809.RA9lWB71G1KR9s8CjH4180GmB14zCze-jwtYpkIino6kA130_assertion SIO_000772 21186003 NP662809.RA9lWB71G1KR9s8CjH4180GmB14zCze-jwtYpkIino6kA130_provenance.
- NP662809.RA9lWB71G1KR9s8CjH4180GmB14zCze-jwtYpkIino6kA130_assertion wasDerivedFrom befree-20150227 NP662809.RA9lWB71G1KR9s8CjH4180GmB14zCze-jwtYpkIino6kA130_provenance.
- NP662809.RA9lWB71G1KR9s8CjH4180GmB14zCze-jwtYpkIino6kA130_assertion wasGeneratedBy ECO_0000203 NP662809.RA9lWB71G1KR9s8CjH4180GmB14zCze-jwtYpkIino6kA130_provenance.